Atlas Venture Fund X L.P. 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:14 pm Purchase |
2022-12-29 | 13D | Gemini Therapeutics, Inc. GMTX |
Atlas Venture Fund X L.P. | 2,237,303 12.900% |
1,835,799 (+457.23%) |
Filing |
| 2021-02-16 5:25 pm Purchase |
2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX |
Atlas Venture Fund X L.P. | 401,505 8.900% |
401,505 (New Position) |
Filing |